
-
2014
Company Description
Faraday Pharmaceuticals is a therapeutics company focused treating ischemia-reperfusion injury.
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury. Faraday has in-licensed proprietary liquid formulations of reduced nonmetal gaseous elements developed in the lab of Dr. Mark Roth at the Fred Hutchinson Cancer Center. The company was founded in 2014 and is located in Seattle, Washington.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Founders:
Christopher Toombs -
Company Website:
-
Company E-mail:
-
Company Address:
1616 Eastlake Ave E, Suite 560Seattle, WAUnited States -
CEO:
- Christopher Toombs
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits